| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.63e-10 | 11 | 22 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.89e-08 | 32 | 22 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.20e-07 | 42 | 22 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.15e-05 | 130 | 22 | 4 | GO:0005200 | |
| GeneOntologyMolecularFunction | stem cell factor receptor binding | 1.16e-05 | 5 | 22 | 2 | GO:0005173 | |
| GeneOntologyMolecularFunction | protein kinase binding | 2.80e-04 | 873 | 22 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | kinase binding | 4.91e-04 | 969 | 22 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 9.26e-04 | 41 | 22 | 2 | GO:0030291 | |
| GeneOntologyMolecularFunction | protein kinase inhibitor activity | 3.56e-03 | 81 | 22 | 2 | GO:0004860 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 4.00e-03 | 86 | 22 | 2 | GO:0019210 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.00e-08 | 31 | 22 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 4.97e-08 | 35 | 22 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | negative regulation of lens fiber cell differentiation | 1.62e-05 | 6 | 22 | 2 | GO:1902747 | |
| GeneOntologyBiologicalProcess | regulation of lens fiber cell differentiation | 4.86e-05 | 10 | 22 | 2 | GO:1902746 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.46e-04 | 17 | 22 | 2 | GO:0043517 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 2.96e-04 | 24 | 22 | 2 | GO:0010801 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 3.07e-04 | 313 | 22 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | positive regulation of signal transduction by p53 class mediator | 5.97e-04 | 34 | 22 | 2 | GO:1901798 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 5.97e-04 | 34 | 22 | 2 | GO:0090311 | |
| GeneOntologyBiologicalProcess | regulation of DNA damage response, signal transduction by p53 class mediator | 8.27e-04 | 40 | 22 | 2 | GO:0043516 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 1.00e-03 | 44 | 22 | 2 | GO:0070306 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 1.14e-03 | 47 | 22 | 2 | GO:0006476 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 1.39e-03 | 52 | 22 | 2 | GO:0010799 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 1.53e-03 | 217 | 22 | 3 | GO:0030856 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial to mesenchymal transition | 1.62e-03 | 56 | 22 | 2 | GO:0010719 | |
| GeneOntologyBiologicalProcess | protein deacylation | 1.73e-03 | 58 | 22 | 2 | GO:0035601 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 2.04e-03 | 63 | 22 | 2 | GO:0098732 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 2.44e-03 | 69 | 22 | 2 | GO:0030857 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.70e-08 | 32 | 24 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.70e-08 | 32 | 24 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.93e-07 | 45 | 24 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.80e-06 | 94 | 24 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.69e-06 | 104 | 24 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.86e-06 | 109 | 24 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | actin filament | 2.18e-05 | 146 | 24 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 3.12e-03 | 899 | 24 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.91e-03 | 576 | 24 | 4 | GO:0015629 | |
| GeneOntologyCellularComponent | transferase complex | 4.20e-03 | 963 | 24 | 5 | GO:1990234 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 4.37e-03 | 972 | 24 | 5 | GO:0140535 | |
| Domain | ANK | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 7.48e-19 | 251 | 24 | 13 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 8.30e-19 | 253 | 24 | 13 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 8.74e-19 | 254 | 24 | 13 | PS50297 |
| Domain | Ankyrin_rpt | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.32e-18 | 262 | 24 | 13 | IPR002110 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG | 7.22e-17 | 254 | 24 | 12 | IPR020683 |
| Domain | Ank_2 | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEF POTEC POTEG | 7.97e-16 | 215 | 24 | 11 | PF12796 |
| Domain | Ank | POTEE POTEI POTEA POTEJ POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.53e-15 | 228 | 24 | 11 | PF00023 |
| Domain | - | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEF POTEC POTEG | 3.88e-15 | 248 | 24 | 11 | 1.25.40.20 |
| Domain | Actin_CS | 3.78e-09 | 16 | 24 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 4.93e-09 | 17 | 24 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 6.34e-09 | 18 | 24 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 8.02e-09 | 19 | 24 | 4 | PS01132 | |
| Domain | ACTIN | 6.45e-08 | 31 | 24 | 4 | SM00268 | |
| Domain | Actin | 6.45e-08 | 31 | 24 | 4 | IPR004000 | |
| Domain | Actin | 6.45e-08 | 31 | 24 | 4 | PF00022 | |
| Domain | KBD | 4.74e-06 | 3 | 24 | 2 | PS51488 | |
| Domain | KBD | 4.74e-06 | 3 | 24 | 2 | IPR023337 | |
| Domain | Sprouty | 3.31e-05 | 7 | 24 | 2 | IPR007875 | |
| Domain | SPR | 3.31e-05 | 7 | 24 | 2 | PS51227 | |
| Domain | Sprouty | 3.31e-05 | 7 | 24 | 2 | PF05210 | |
| Domain | WH1 | 8.64e-05 | 11 | 24 | 2 | SM00461 | |
| Domain | WH1/EVH1_dom | 8.64e-05 | 11 | 24 | 2 | IPR000697 | |
| Domain | WH1 | 8.64e-05 | 11 | 24 | 2 | PF00568 | |
| Domain | WH1 | 1.22e-04 | 13 | 24 | 2 | PS50229 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 5.43e-06 | 6 | 9 | 2 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 7.60e-06 | 7 | 9 | 2 | M29717 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 2.82e-05 | 13 | 9 | 2 | M27540 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 2.82e-05 | 13 | 9 | 2 | MM15262 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 4.37e-04 | 50 | 9 | 2 | MM15255 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 4.73e-04 | 52 | 9 | 2 | M27530 | |
| Pathway | PID_KIT_PATHWAY | 4.73e-04 | 52 | 9 | 2 | M231 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 7.61e-04 | 66 | 9 | 2 | MM15261 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 8.08e-04 | 68 | 9 | 2 | M27539 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 8.80e-04 | 71 | 9 | 2 | MM15947 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 1.03e-03 | 77 | 9 | 2 | MM14722 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.17e-03 | 82 | 9 | 2 | M27626 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 1.38e-03 | 89 | 9 | 2 | M1090 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 4.11e-03 | 155 | 9 | 2 | M17411 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.64e-02 | 318 | 9 | 2 | MM15278 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.73e-02 | 327 | 9 | 2 | M27565 | |
| Pubmed | 2.04e-26 | 8 | 25 | 8 | 12475935 | ||
| Pubmed | 3.94e-23 | 7 | 25 | 7 | 15276201 | ||
| Pubmed | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG | 3.67e-22 | 163 | 25 | 12 | 24316575 | |
| Pubmed | 7.21e-20 | 6 | 25 | 6 | 17171436 | ||
| Pubmed | 6.05e-18 | 9 | 25 | 6 | 16364570 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.59e-16 | 15 | 25 | 6 | 16824795 | |
| Pubmed | 2.08e-13 | 4 | 25 | 4 | 17342726 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.28e-10 | 3 | 25 | 3 | 17101985 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25690936 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11493923 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 4.96e-07 | 2 | 25 | 2 | 19669888 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16652141 | ||
| Pubmed | Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. | 4.96e-07 | 2 | 25 | 2 | 18447647 | |
| Pubmed | Distinct requirements for the Sprouty domain for functional activity of Spred proteins. | 4.96e-07 | 2 | 25 | 2 | 15683364 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15465815 | ||
| Pubmed | 6.59e-07 | 96 | 25 | 4 | 23580065 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 15184877 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 21364986 | ||
| Pubmed | Expression and subcellular localization of Spred proteins in mouse and human tissues. | 1.49e-06 | 3 | 25 | 2 | 15580519 | |
| Pubmed | Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress. | 1.49e-06 | 3 | 25 | 2 | 29706577 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 19120036 | ||
| Pubmed | Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. | 2.97e-06 | 4 | 25 | 2 | 12646235 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 26075267 | ||
| Pubmed | 3.82e-06 | 149 | 25 | 4 | 22664934 | ||
| Pubmed | Personalized copy number and segmental duplication maps using next-generation sequencing. | 4.95e-06 | 5 | 25 | 2 | 19718026 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 20736167 | ||
| Pubmed | Negative regulation of lens fiber cell differentiation by RTK antagonists Spry and Spred. | 7.43e-06 | 6 | 25 | 2 | 29501879 | |
| Pubmed | The negative regulatory Spred1 and Spred2 proteins are required for lens and eye morphogenesis. | 7.43e-06 | 6 | 25 | 2 | 31923414 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 38391903 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 25576668 | ||
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 17438136 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 17974561 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.01e-05 | 271 | 25 | 4 | 32433965 | |
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 26362256 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 5.08e-05 | 288 | 25 | 4 | 31501420 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 8.96e-05 | 1070 | 25 | 6 | 23533145 | |
| Pubmed | Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromes. | 1.03e-04 | 21 | 25 | 2 | 32452519 | |
| Pubmed | 1.14e-04 | 22 | 25 | 2 | 25331947 | ||
| Pubmed | Fgf9 signalling stimulates Spred and Sprouty expression in embryonic mouse pancreas mesenchyme. | 1.24e-04 | 23 | 25 | 2 | 20934536 | |
| Interaction | POTEG interactions | 1.21e-12 | 12 | 24 | 5 | int:POTEG | |
| Interaction | POTEC interactions | 1.96e-12 | 13 | 24 | 5 | int:POTEC | |
| Interaction | POTEB3 interactions | 4.87e-10 | 35 | 24 | 5 | int:POTEB3 | |
| Interaction | POTED interactions | 5.93e-09 | 4 | 24 | 3 | int:POTED | |
| Interaction | ACTG2 interactions | 3.16e-07 | 49 | 24 | 4 | int:ACTG2 | |
| Interaction | POTEH interactions | 1.36e-06 | 2 | 24 | 2 | int:POTEH | |
| Interaction | POTEA interactions | 2.03e-05 | 6 | 24 | 2 | int:POTEA | |
| Interaction | POTEB2 interactions | 2.03e-05 | 6 | 24 | 2 | int:POTEB2 | |
| Interaction | POTEJ interactions | 3.16e-05 | 52 | 24 | 3 | int:POTEJ | |
| Interaction | CAP2 interactions | 6.46e-05 | 66 | 24 | 3 | int:CAP2 | |
| Interaction | ATPSCKMT interactions | 7.43e-05 | 11 | 24 | 2 | int:ATPSCKMT | |
| Interaction | POTEF interactions | 1.42e-04 | 228 | 24 | 4 | int:POTEF | |
| Interaction | PFDN2 interactions | 1.93e-04 | 247 | 24 | 4 | int:PFDN2 | |
| Interaction | POTEI interactions | 2.57e-04 | 105 | 24 | 3 | int:POTEI | |
| Interaction | ADAR interactions | 3.37e-04 | 286 | 24 | 4 | int:ADAR | |
| Interaction | ACTBL2 interactions | 3.84e-04 | 296 | 24 | 4 | int:ACTBL2 | |
| Interaction | POTEE interactions | 5.25e-04 | 134 | 24 | 3 | int:POTEE | |
| Interaction | HPCAL4 interactions | 5.79e-04 | 30 | 24 | 2 | int:HPCAL4 | |
| Interaction | TESK1 interactions | 6.60e-04 | 32 | 24 | 2 | int:TESK1 | |
| Interaction | ACTA2 interactions | 7.61e-04 | 355 | 24 | 4 | int:ACTA2 | |
| Interaction | VSNL1 interactions | 8.82e-04 | 37 | 24 | 2 | int:VSNL1 | |
| Interaction | ACTA1 interactions | 8.97e-04 | 371 | 24 | 4 | int:ACTA1 | |
| Interaction | CEP83 interactions | 9.80e-04 | 39 | 24 | 2 | int:CEP83 | |
| Cytoband | 2q21.1 | 2.84e-08 | 58 | 25 | 4 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.35e-06 | 151 | 25 | 4 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 2.22e-04 | 217 | 25 | 3 | chr15q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p15 | 2.46e-03 | 135 | 25 | 2 | chr4p15 | |
| Cytoband | 15q11.2 | 3.96e-03 | 172 | 25 | 2 | 15q11.2 | |
| Cytoband | 14q11.2 | 4.32e-03 | 180 | 25 | 2 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 1.40e-02 | 332 | 25 | 2 | chr14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 2.17e-02 | 419 | 25 | 2 | chr22q11 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 2.58e-37 | 13 | 19 | 12 | 685 |
| GeneFamily | Ankyrin repeat domain containing | POTEE POTEI POTEA POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.17e-18 | 242 | 19 | 12 | 403 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | POTEB3 POTEE POTEI POTEA POTEJ POTEB2 SPRED2 POTEM POTEH POTEB POTEF POTEC POTEG | 5.83e-16 | 584 | 24 | 13 | MM1080 |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.71e-12 | 92 | 24 | 7 | MM503 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 1.68e-07 | 282 | 24 | 6 | MM3642 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 2.88e-07 | 309 | 24 | 6 | MM1244 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 6.85e-07 | 188 | 24 | 5 | MM1071 | |
| Coexpression | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN | 3.60e-05 | 10 | 24 | 2 | M19367 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.29e-12 | 90 | 25 | 6 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.38e-10 | 63 | 25 | 5 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.62e-07 | 136 | 25 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.62e-07 | 136 | 25 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.93e-06 | 180 | 25 | 4 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.93e-06 | 180 | 25 | 4 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.03e-05 | 95 | 25 | 3 | 48ad5d89ee9a1941d1d3dbdbfb03893a390c0d64 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.09e-05 | 96 | 25 | 3 | 4cca2f5e754b82075740adaa0a147d16368be908 | |
| ToppCell | TCGA-Prostate|World / Sample_Type by Project: Shred V9 | 4.39e-05 | 123 | 25 | 3 | 22b38555652b7a426a6277ed385361ae275310a3 | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 4.72e-05 | 126 | 25 | 3 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 6.45e-05 | 140 | 25 | 3 | 3f003320d797f18d2dfc38eab7f094f75027958e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-05 | 156 | 25 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-05 | 156 | 25 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| Disease | lung adenocarcinoma | 2.19e-03 | 174 | 12 | 2 | EFO_0000571 | |
| Disease | attempted suicide | 2.30e-03 | 178 | 12 | 2 | EFO_0004321 | |
| Disease | tonsillectomy risk measurement | 4.82e-03 | 260 | 12 | 2 | EFO_0007924 | |
| Disease | mean corpuscular hemoglobin concentration | 8.94e-03 | 1105 | 12 | 3 | EFO_0004528 | |
| Disease | basophil count | 1.58e-02 | 483 | 12 | 2 | EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGKWCCHCFPCCRGS | 61 | H3BUK9 | |
| MGKWCRHCFPCCRGS | 61 | A5A3E0 | |
| NKMGKWCCHCFPCCR | 96 | A5A3E0 | |
| MGKCCHHCFPCCRGS | 61 | A0JP26 | |
| SKMGKWCCHCFPCCR | 96 | A0JP26 | |
| WCCHCFPCCRGSGKS | 101 | A0JP26 | |
| VHKVCCPCCFGRGCL | 166 | Q8TCG2 | |
| MGKWCHHCFPCCRGS | 61 | Q6S8J3 | |
| NKMGKWCCHCFPCCR | 96 | Q6S8J3 | |
| WCCHCFPCCRGSGKS | 101 | Q6S8J3 | |
| CLCKPFSRAFMECCC | 551 | O15354 | |
| RGKMGKWCCCCFPCC | 21 | Q6S8J7 | |
| MGKCCHHCFPCCRGS | 61 | B2RU33 | |
| SKMGKWCCHCFPCCR | 96 | B2RU33 | |
| WCCHCFPCCRGSGKS | 101 | B2RU33 | |
| CCPMGCAKCAQGCVC | 36 | Q93083 | |
| MGKCCRHCFPCCRGS | 61 | Q86YR6 | |
| SKMGKWCCHCFPCCR | 96 | Q86YR6 | |
| WCCHCFPCCRGSGKS | 101 | Q86YR6 | |
| CSMRCGALDGPCSCH | 31 | Q9UGT4 | |
| MGKWCCHCFPCCRGS | 61 | A0A0A6YYL3 | |
| CMCRCCNKCGGEMHQ | 131 | O43490 | |
| MGKWCCHCFPCCRGS | 61 | P0CG39 | |
| PCRLCGGLLCHACSM | 536 | Q6ZNE9 | |
| MGKWCCHCFPCCRGS | 61 | P0CG38 | |
| SKMGKWCCHCFPCCR | 96 | P0CG38 | |
| WCCHCFPCCRGSGKS | 101 | P0CG38 | |
| CMCCYVPLRMCHRCG | 416 | Q7Z699 | |
| VPLRMCHRCGEACGC | 421 | Q7Z699 | |
| PLRACYHCGVMCRCC | 396 | Q7Z698 | |
| CGCCGHENCGKRCAM | 76 | P30408 | |
| SGVRCCCQMCCGPFL | 391 | Q8N3G9 | |
| CCRRTCHSCGCGCGK | 91 | A0A286YFB4 | |
| SKMGKWCCHCFPCCR | 96 | Q6S5H5 | |
| WCCHCFPCCRGSGKS | 101 | Q6S5H5 | |
| SKMGKWCCHCFPCCR | 96 | Q6S545 | |
| WCCHCFPCCRGSGKS | 101 | Q6S545 | |
| GKWCCHCFPCCRGSG | 136 | Q6S545 | |
| SKMGKWCCHCFPCCR | 96 | A6NI47 | |
| WCCHCFPCCRGSGKS | 101 | A6NI47 | |
| CIFCCGCCHRSKCGM | 66 | P81172 |